Loading asset research
NeuroSense Therapeutics Ltd. Ordinary Shares
NRSNNasdaq · USD · StocksQuote as of · Exchange session not verified$0.347
+4.52%
Today
NRSN
Loading 1D prices…
Market cap
$658.6K
Volume
227.5K
52w high
$1.3352w low
$0.25Company profile
NeuroSense Therapeutics Ltd. Ordinary Shares
NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from neurodegenerative diseases in the United States and internationally. The company's lead product is PrimeC, an extended-release oral formulation of a fixed-dose combination of ciprofloxacin and celecoxib, currently under Phase 2b/3 clinical trials for the treatment of amyotrophic lateral sclerosis, and completed Phase 2 clinical trials for the treatment of Alzheimer's, as well as under preclinical studies for the treatment of Parkinson's disease. Its preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer's disease. NeuroSense Therapeutics Ltd. was incorporated in 2017 and is headquartered in Herzliya, Israel.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Herzliya, Israel, United States
Employees
17
Fiscal year end
1231
CIK
1875091
Session & valuation
Open$0.345
Previous close$0.332
Day high$0.349
Day low$0.33
30-day avg. volume512.6K
Outstanding shares32.6M
Diluted EPS-$0.44
Latest annual period
P/E (trailing)-0.79
P/E (forward)-0.51
Price / book-7.23
Beta1.58
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| BDRXBiodexa Pharmaceuticals plc American Depositary Shs | $1.3M | — | — | -$0.50 | +96.97% | Unrated |
| CMNDClearmind Medicine Inc. Common Shares | $1.4M | $0.00 | — | -$303.50 | -1.53% | Unrated |
| JAGXJaguar Health Inc. Common Stock | $1.6M | $11.5M | -0.47% | -$22.97 | -1.57% | Unrated |
| DCOYDecoy Therapeutics Inc. Common Stock | $1.7M | $0.00 | — | -$129.10 | -2.20% | Buy |
| RNAZTransCode Therapeutics Inc. Common Stock | $1.8M | $0.00 | — | -$52.59 | 0.00% | Unrated |